Agentic AI in healthcare is graduating from answering prompts to autonomously executing complex marketing tasks – and life sciences companies are betting their commercial strategies on it. According to a recent report cited by Capgemini Invent, AI agents could generate up to $450 billion in economic value through revenue uplift and cost savings globally by 2028, with 69% of executives planning to deploy agents in marketing processes by year’s end. The stakes are particularly high in pharmaceutical marketing, where sales representatives have increasingly limited face-time with healthcare professionals (HCPs) – a trend accelerated by Covid-19. The challenge isn’t just access; it’s making those rare interactions count with intelligence that’s currently trapped in data silos.

Full report on Agentic AI in healthcare: How Life Sciences marketing could achieve $450B in value by 2028.